Bridgewater Bancshares Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bridgewater Bancshares Inc. on July 8, 2021. The filing discloses the entry into a material definitive agreement involving the issuance of subordinated notes to institutional investors.
Key Financial Metrics and Transaction Details
- Transaction Amount: $30.0 million aggregate principal amount.
- Instrument: 3.25% Fixed-to-Floating Rate Subordinated Notes due 2031.
- Interest Rate: Fixed at 3.25% per year from July 8, 2021, to July 15, 2026. Thereafter, the rate resets quarterly to three-month SOFR plus 252 basis points.
- Use of Proceeds: General corporate purposes, supporting organic growth, maintaining bank-level capital ratios, and potentially redeeming or repurchasing outstanding indebtedness.
- Capital Classification: The Notes are intended to qualify as Tier 2 capital for regulatory purposes.
- Financial Results: The filing does not provide finalized revenue, profit, or cash flow figures for the quarter ended June 30, 2021, noting that preliminary estimates in an investor presentation should not be relied upon.
Material Changes and Obligations
The Company created a direct financial obligation by issuing unsecured, subordinated debt. The Notes rank junior to the Company's current and future senior indebtedness. The Company entered into a Registration Rights Agreement, agreeing to facilitate an exchange offer for registered notes under certain circumstances. Failure to meet obligations under this agreement could trigger additional interest payments.
Outlook, Risks, and Contingencies
- Redemption Terms: The Notes are redeemable in whole or in part on or after July 15, 2026. Prior to this date, redemption is permitted only under limited circumstances.
- Forward-Looking Statements: The filing includes forward-looking statements regarding the use of proceeds and the Exchange Offer, which are subject to risks and uncertainties.
- Unusual Items: The transaction was conducted as a private placement under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
Key Facts for Investor Verification
- Verify the impact of the $30.0 million issuance on the Company's regulatory capital ratios.
- Confirm the specific terms of the Registration Rights Agreement and potential costs associated with the Exchange Offer.
- Monitor the Company's finalized financial statements for the quarter ended June 30, 2021, as preliminary estimates were not finalized at the time of filing.
- Review the Indenture for specific "limited circumstances" allowing redemption prior to July 15, 2026.